BEVACIZUMAB AS 4TH LINE TREATMENT IN METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Cannella, Lucia [1 ]
Carlomagno, Chiara [1 ]
De Stefano, Alfonso [1 ]
Alfieri, Salvatore [1 ]
Colantuoni, Maria [1 ]
Cella, Chiara [1 ]
De Placido, Sabino [1 ]
机构：
[1] Univ Federico II, Dept Endocrinol & Mol & Clin Oncol, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [1] Determinants of cetuximab (CETUX) reversal of resistance to chronomodulated chemotherapy (CHRONO) as 4th line treatment of metastatic colorectal cancer (MCC)
    Levi, Francis
    Karaboue, Abdoulaye
    Bralet, Marie-Pierre
    Innominato, Pasquale
    Moreau, Thierry
    Herelle, Marie-Olga
    Hauteville, Dominique
    Adam, Rene
    Guettier, Catherine
    Bouchahda, Mohamed
    ANNALS OF ONCOLOGY, 2006, 17 : 123 - 123
  • [2] Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer
    Park, Lee Chun
    Lee, Ho Sup
    Shin, Seong Hoon
    Park, Seun Ja
    Park, Moo In
    Oh, Sung Yong
    Kwon, Hyuk Chan
    Baek, Jin Ho
    Choi, Young Jin
    Kang, Myoung Joo
    Kim, Yang Soo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (10) : 1104 - 1109
  • [3] BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
    Ubago, R.
    Castillo, M. A.
    Flores, S.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A435 - A435
  • [4] Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer
    Lee Chun Park
    Ho Sup Lee
    Seong Hoon Shin
    Seun Ja Park
    Moo In Park
    Sung Yong Oh
    Hyuk Chan Kwon
    Jin ho Baek
    Young Jin Choi
    Myoung Joo Kang
    Yang Soo Kim
    World Journal of Gastroenterology, 2012, (10) : 1104 - 1109
  • [5] Use of bevacizumab in the treatment of metastatic colorectal cancer
    Raouf, Sherif
    Bridgewater, John
    Ellis, Richard
    Ferry, David
    Hill, Mark
    Wasan, Harpreet
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (01) : 25 - 30
  • [6] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Cherciu, Nelly
    Petria, Cristina
    ANNALS OF ONCOLOGY, 2012, 23 : 92 - 92
  • [7] TREATMENT WITH BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Ocvirk, Janja
    Rebersek, Martina
    Benedik, Jernej
    Volk, Neva
    ANNALS OF ONCOLOGY, 2011, 22 : v96 - v96
  • [8] Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
    Strickler, John H.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2012, 17 (04): : 513 - 524
  • [9] Evaluation of safety of bevacizumab as second-line treatment of patients with metastatic colorectal cancer
    Todorovic, Vladimir
    Saric, Nada Cicmil
    Lakicevic, Jadranka
    Sorat, Milan
    JOURNAL OF BUON, 2017, 22 (05): : 1131 - 1136
  • [10] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    Feliu, J.
    Safont, M. J.
    Salud, A.
    Losa, F.
    Garcia-Giron, C.
    Bosch, C.
    Escudero, P.
    Lopez, R.
    Madronal, C.
    Bolanos, M.
    Gil, M.
    Llombart, A.
    Castro-Carpeno, J.
    Gonzalez-Baron, M.
    BRITISH JOURNAL OF CANCER, 2010, 102 (10) : 1468 - 1473
12345